Saturday, May 9, 2026Aggregating 2,418 sources · Updated 38 seconds agoNYC 54° · LON 47° · TOK 61°
Front PageWorld NewsTHE GUARDIAN
World News

FDA blocked studies finding Covid and shingles vaccines safe, HHS official says

THE GUARDIAN·4d ago·3 min read
Photograph via The Guardian
RSS SUMMARY · AGGREGATED FROM THE GUARDIAN

Serious side effects from vaccines were rare, scientists found in studies funded by US taxpayer moneyThe US Food and Drug Administration has blocked the publication of several studies that found Covid-19 and shingles vaccines to be safe, according to a spokesperson from the Department of Health and Human Services.Agency scientists conducted the studies by analyzing millions of patient records and found that serious side effects from the vaccines were rare, the spokesperson confirmed. The studies – funded by taxpayer money and costing several million dollars – included research examining the safety of Covid-19 vaccines in 2023 and 2024. Continue reading…

Serious side effects from vaccines were rare, scientists found in studies funded by US taxpayer moneyThe US Food and Drug Administration has blocked the publication of several studies that found Covid-19 and shingles vaccines to be safe, according to a spokesperson from the Department of Health and Human Services.Agency scientists conducted the studies by analyzing…

Serious side effects from vaccines were rare, scientists found in studies funded by US taxpayer moneyThe US Food and Drug Administration has blocked the publication of several studies that found Covid-19 and shingles vaccines to be safe, according to a spokesperson from the Department of Health and Human Services.Agency scientists conducted the studies by analyzing millions of patient records and found that serious side effects from the vaccines were rare, the spokesperson confirmed. The studies – funded by taxpayer money and costing several million dollars…

Continue Reading

The full story continues on The Guardian.

Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.